Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 1,969,724 shares at $41.26 ($83.2M) on 2021-06-29, disclosed to the SEC on 2021-06-29.
Open-market sale of $83.2M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.69 | 487,364 | $20.8M | 25.0% |
| 2 | $42.69 | 487,364 | $20.8M | 25.0% |
| 3 | $42.81 | 179,100 | $7.7M | 9.2% |
| 4 | $42.11 | 167,448 | $7.1M | 8.5% |
| 5 | $42.11 | 167,448 | $7.1M | 8.5% |
| 6 | $41.26 | 479,800 |
| $19.8M |
| 23.8% |
| 7 | $42.01 | 1,200 | $50K | 0.1% |
| Total | $42.25 avg | 1,969,724 | $83.2M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |